We see the MOU that KPJ signed for the development of KPJ Damansara Specialist 2 as positive and long overdue. The new hospitalis slated to cater to the rising demand for private healthcare in the Damansara-Sungai Buloh vicinity. As the building will take 36 months to complete, we maintain our earnings forecasts at this juncture.Maintain NEUTRAL with a MYR3.67 TP (1.1% downside, 26x FY15F P/E).
Details on the MOU. KPJ Healthcare (KPJ) signed a memorandum of understanding (MOU) on 16 Oct with Pelaburan Hartanah (PHB) and Nadayu Properties (NPB) for the proposed development and lease of a purpose-built hospital building, to be known as KPJ Damansara Specialist 2. The MOU will see NPB developing a 300-bed, 9-storey hospital building and a 636-bay car park with a certificate of completion and compliance (CCC) for PHB within 36 months from the agreed execution date. PHB will then execute a sale-and-purchase agreement (SPA) with NPB for the purchase of both the land and building. Subsequently, it will lease the building to KPJ for a 15-year period, with an option of a renewal for another 15 years. The development will also include a new exit ramp to the hospital. However, at this point in time, matters relating to the timeline and costs for the development have yet tobe finalised and disclosed.
Details on the land. The land on which the hospital is to be built is located in Mukim Batu, close to Sungai Penchala in Kuala Lumpur. The total area is expected to be approximately 6.176 acres. The hospital willoccupy 2.95 acres of the gross area once it is completed.
Rationale of MOU. The three parties signed the MOU due to increasing development funding costs. Management believes that established Tier-1 hospitals like KPJ Damansara can afford to pay rent immediately, thereby easing capex that can be channeled towards new hospitals in smaller towns. KPJ Damansara Specialist has 211 beds currently.
Forecasts. We make no changes to our earnings forecasts at this juncture as management disclosed that the hospital requires 36 months to be developed. It also requires an additional 3-6 months to obtain approvals from relevant authorities before it can be open to public.
Maintain NEUTRAL. We maintain our NEUTRAL call and TP of MYR3.67 pending further disclosure on the development. Our TP is pegged to a 26x FY15F P/E, in line with its average 3-year forward P/E.
Source: RHB
Chart | Stock Name | Last | Change | Volume |
---|
2024-10-03
KPJ2024-10-03
KPJ2024-10-03
KPJ2024-10-02
KPJ2024-10-02
KPJ2024-10-02
KPJ2024-10-01
KPJ2024-10-01
KPJ2024-10-01
KPJ2024-09-30
KPJ2024-09-30
KPJ2024-09-30
KPJ2024-09-27
KPJ2024-09-27
KPJ2024-09-27
KPJ2024-09-26
KPJ2024-09-26
KPJ2024-09-26
KPJ2024-09-26
KPJ2024-09-26
KPJ2024-09-25
KPJ2024-09-25
KPJ2024-09-25
KPJ2024-09-24
KPJ2024-09-24
KPJ2024-09-24
KPJ2024-09-24
KPJ2024-09-23
KPJ2024-09-23
KPJCreated by kiasutrader | Jun 14, 2016
Created by kiasutrader | May 05, 2016